Caffeine in the Prevention of Post-operative Nausea and Vomiting

Completed · Not applicable

Conditions studied: Postoperative Nausea and Vomiting

In brief

The objective of this study is to determine if caffeine 500 mg intravenously is efficacious when added to standard anti-emetic prophylaxis in the prevention of post-operative nausea and vomiting (PONV) in patients undergoing ambulatory surgery under general anesthesia.

Key facts

Study ID

NCT00130026

Run by

Beth Israel Deaconess Medical Center

People needed

135

Starts

2005-03-01

Expected to finish

2005-10-01

Last updated by the study team

2017-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient having ambulatory surgery
• Patient receiving general anesthesia

You may not qualify if…

• Patient is not willing to sign informed consent
• Patient does not speak or understand sufficient English

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.